Focused panels for hereditary cancer
Offering disease-specific insights
For patients diagnosed with certain cancers, such as breast or prostate cancer, disease-specific panels focus on certain cancers to help providers understand their patients’ risk of having a hereditary cancer syndrome. Mayo Clinic Laboratories’ disease-specific cancer panels utilize next generation sequencing to detect germline variations associated with an increased cancer risk.
Key testing
BRGYP | Hereditary Breast/Gynecologic Cancer Panel, Varies
HBOCZ | BRCA1/BRCA2 Genes, Full Gene Analysis, Varies
CRCGP | Hereditary Gastrointestinal Cancer Panel, Varies
LYNCP | Lynch Syndrome Panel, Varies
WILMP | Hereditary Wilms Tumor Panel, Varies
RENCP | Hereditary Renal Cancer Panel, Varies
PRS8P | Hereditary Prostate Cancer Panel, Varies
PANCP | Hereditary Pancreatic Cancer Panel, Varies
ENDCP | Hereditary Endocrine Cancer Panel, Varies
HPGLP | Hereditary Paraganglioma/Pheochromocytoma Panel, Varies
THYRP | Hereditary Thyroid Cancer Panel, Varies